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The impact of environmental toxicants on
children’s health is increasingly being recog-
nized as signiﬁcant [Faustman 2000; Greater
Boston Physicians for Social Responsibility
(GBPSR) 2000; Landrigan et al. 1999; Perera
et al. 1999; U.S. Environmental Protection
Agency (EPA) 1996]. Human and experi-
mental studies indicate that the fetus and
infant are more sensitive than adults to many
environmental toxicants, including environ-
mental tobacco smoke (ETS), and polycyclic
aromatic hydrocarbons (PAHs) (Mott et al.
1994; National Academy of Sciences 1993;
World Health Organization (WHO) 1986;
Whyatt and Perera 1995]. Urban, minority
populations represent high-risk groups for
adverse birth outcomes [New York City
Department of Health (NYCDH) 1998;
Perera et al. 2002]. These same populations
are likely to be more heavily exposed to ambi-
ent air pollution and ETS (Chen and Petitti
1995; Heritage 1992; Metzer et al. 1995;
Olden and Poje 1995; Pirkle et al. 1996;
Wagenknecht et al. 1993; Wernette and
Nieves 1992). However, only limited infor-
mation is available on the extent and impact
of prenatal exposure to these environmental
contaminants on fetal growth and develop-
ment. Etiologic studies have largely been eco-
logic in nature, lacking individual-level data
on exposure.
In the present study, we evaluated the
effects of prenatal exposure to common urban
pollutants: environmental PAHs estimated
by DNA adducts in white blood cells (WBCs)
formed by benzo[a]pyrene (BaP), a repre-
sentative PAH, and ETS estimated by ques-
tionnaire data and plasma concentrations
of cotinine. In addition to being genotoxic and
carcinogenic, PAHs such as BaP are endocrine
disruptors (Bostrom et al. 2002; Bui et al.
1986; Davis et al. 1993). Prior laboratory and
two human studies in Central Europe indicate
that transplacental exposure to PAHs at rela-
tively high concentrations (annual average air-
borne concentrations of 7–17 ng/m3 BaP in
the human studies) is associated with adverse
birth outcomes (Barbieri et al. 1986; Bui et al.
1986; Dejmek et al. 2000; Legraverend et al.
1984; Perera et al. 1998). We recently reported
that prenatal PAH exposure estimated by per-
sonal air monitoring was associated with
reduced birth weight and head circumference
among African Americans in the present New
York City, New York, cohort (Perera at al.
2003). ETS is a complex mixture of > 4,000
chemicals, including PAHs and carbon
monoxide (Leikauf et al. 1995). ETS meas-
ured by self-report or by biomarkers such as
cotinine has been shown in many studies to
adversely affect fetal growth as well as child
growth and development (reviewed in
Eskenazi et al. 1995; Etzel 1997; National
Research Council 1986). Adverse effects
include deﬁcits in birth weight, birth length,
and cognitive functioning at age 3 (Janerich
et al. 1990; Martinez et al. 1994; Schuster-
Kolbe and Ludwig 1994; Sexton et al. 1990).
Likely mechanisms underlying the adverse
effects of fetal exposure to ETS include anti-
estrogenic effects, induction of P450 enzymes,
DNA damage resulting in activation of apop-
totic pathways, binding to receptors for pla-
cental growth factors resulting in decreased
exchange of oxygen and nutrients, and direct
effects of carbon monoxide.
Here we tested the hypothesis that pre-
natal exposure to environmental pollutants
alone and/or in combination is negatively
associated with birth weight, length, and head
circumference, after controlling for the effects
of known physical, biologic, and toxic deter-
minants of fetal growth. As reported previ-
ously, the study cohort has substantial exposure
to multiple contaminants during pregnancy
(Perera et al. 2002; Whyatt et al. 2002, 2003).
Specifically, analysis of PAHs in air samples
from the first 250 subjects showed that all
samples had detectable levels of one or more
carcinogenic PAHs, ranging across 4 orders
of magnitude (Perera et al. 2002). Almost
half of the mothers and infants initially
enrolled had cotinine levels indicative of ETS
exposure (≥ 0.05–25 ng/mL). Maternal and
newborn plasma cotinine levels were signifi-
cantly higher for mothers who reported
smoking by others in the household than for
mothers who reported no smoking in the
home (p < 0.001).
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Inner-city, minority populations are high-risk groups for adverse birth outcomes and also are more
likely to be exposed to environmental contaminants, including environmental tobacco smoke
(ETS), benzo[a]pyrene (BaP), and other polycyclic aromatic hydrocarbons (PAHs) found in urban
air. In a sample of nonsmoking African-American and Dominican women, we evaluated the effects
on birth outcomes of prenatal exposure to ETS, using questionnaire data and plasma cotinine as a
biomarker of exposure, and environmental PAHs using BaP-DNA adducts as a molecular dosime-
ter. We previously reported that among African Americans, high prenatal exposure to PAHs esti-
mated by prenatal personal air monitoring was associated with lower birth weight (p = 0.003) and
smaller head circumference (p = 0.01) after adjusting for potential confounders. In the present
analysis, self-reported ETS was associated with decreased head circumference (p = 0.04). BaP-DNA
adducts were not correlated with ETS or dietary PAHs. There was no main effect of BaP-DNA
adducts on birth outcomes. However, there was a signiﬁcant interaction between the two pollutants
such that the combined exposure to high ETS and high adducts had a significant multiplicative
effect on birth weight (p = 0.04) and head circumference (p = 0.01) after adjusting for ethnicity, sex
of newborns, maternal body mass index, dietary PAHs, and gestational age. This study provides
evidence that combined exposure to environmental pollutants at levels currently encountered in
New York City adversely affects fetal development. Key words: adducts, birth outcomes, develop-
ment, environmental, ETS, PAHs, pollutants, prenatal. Environ Health Perspect 112:626–630
(2004). doi:10.1289/ehp.6617 available via http://dx.doi.org/ [Online 14 January 2004]Materials and Methods
Study subjects. Study subjects are Dominican
and African-American women residing in
Washington Heights, Central Harlem, and
the South Bronx, New York, who delivered
at New York Presbyterian Medical Center
(NYPMC), Harlem Hospital (HH), or their
satellite clinics (Perera et al. 2002; Whyatt
et al. 2002); Table 1 presents demographic
and exposure characteristics of the popula-
tion. Ethnicity was self-identified. Women
were eligible if they were nonsmokers; were
18–35 years of age; were registered at the
obstetrics and gynecology clinics at NYPMC
and HH by the 20th week of pregnancy; were
free of diabetes, hypertension, or known
HIV; and had resided in the area for at least
1 year. The mean gestational age at enroll-
ment was 39.5 weeks. Two hundred ninety-
eight women were considered to be fully
enrolled in the study; that is, they had been
monitored prenatally during the third tri-
mester using a personal air monitor and had
delivered, and a maternal and/or umbilical
cord blood sample had been collected.
The 214 subjects included in the present
analysis are those with adduct measurements in
umbilical cord blood samples (in some cases
the amount of blood collected was inadequate
for the assay), and complete questionnaire and
medical record data were used as covariates in
the multiregression models. Fully enrolled sub-
jects missing any of these data points (n = 84)
were excluded from the analysis. Only non-
smokers were included. Nonsmokers were ini-
tially deﬁned as having answered “no” to the
question “presently, does a household member
or regular visitor to your home smoke ciga-
rettes, pipes, marijuana, or cigars in your
home” and as having plasma cotinine concen-
trations ≤ 15 ng/mL. Cotinine data were avail-
able for approximately 90% of the subjects.
Three subjects with plasma cotinine concentra-
tions > 15 ng/mL were excluded to rule out
active smoking. There were no signiﬁcant dif-
ferences in sociodemographic characteristics or
levels of exposure between the present subset
and fully enrolled subjects with missing data
required in the present analysis.
Personal interview. A 45-min question-
naire was administered by a trained bilingual
interviewer during the last trimester of preg-
nancy. The questionnaire included demo-
graphic information, lifetime residential
history (country of birth, location, and dura-
tion of residence), travel outside the current
area of residence during the past year, history
of active and passive smoking (including
number of household members who smoke),
alcohol use during each trimester of preg-
nancy, and consumption of PAH-containing
meat (frequency of eating fried, broiled, or
barbecued meat during the last 2 weeks).
Socioeconomic information related to income
and education was also collected. The ques-
tionnaire was based on that used in a prior
study of women and newborns and adapted
for the New York City population (Perera
et al. 1998).
Biologic sample collection and analysis.
Maternal blood (30–35 mL) was collected
within 1 day postpartum, and umbilical cord
blood (30–60 mL) was collected at delivery.
Samples were transported to the laboratory
immediately. The buffy coat, packed red
blood cells, and plasma samples were sepa-
rated and stored at –70°C. A portion of each
sample was shipped to the Centers for Disease
Control and Prevention (CDC) for analysis
of cotinine (2 mL) and pesticides (10 mL).
Plasma cotinine was analyzed by the CDC
using high-performance liquid chromatogra-
phy atmospheric-pressure ionization tandem
mass spectrometry as described previously
(Bernert et al. 1997, 2000). The limit of
detection for cotinine was 0.05 ng/mL.
DNA adducts. BaP-DNA adducts in
extracted WBC DNA from maternal and cord
blood were analyzed by the HPLC/fluores-
cence method of Alexandrov et al. (1992),
which uses an HPLC method to detect BaP
tetromers. This assay is a sensitive and speciﬁc
method for measuring BaP-DNA adducts in
WBCs from individuals exposed to BaP
(Bartsch 1996). The method has a coefﬁcient
of variation of 12%. Samples from mother–
child pairs were run in the same batch.
Measures relevant to birth outcomes.
Information abstracted by the research workers
from mothers’ and infants’ medical records
after delivery included date of delivery; ges-
tational age at birth (based on the last men-
strual period); infant sex, birth weight, length,
head circumference, infant malformations, and
Apgar scores; maternal height, prepregnancy
weight, and total weight gain; complications of
pregnancy and delivery; and medications used
during pregnancy.
Statistical analysis. As described above, to
exclude active smokers we removed subjects
with cotinine levels > 15 ng/mL. Additional
analyses were also done after further removing
the nine subjects who reported smoking any
amount during pregnancy, and the results
were materially unchanged. Adducts were
used both as a continuous variable and as
a dichotomous one. We deﬁned high adducts
as > 0.36 adducts/10–8 nucleotides (the
median of the detectable adduct values or
the upper 20% percentile). As in prior stud-
ies, in the analysis of the relationship between
adducts and birth outcomes, cord blood
adducts were used as the independent variable
(Perera et al. 2000). The maternal and cord
plasma concentrations of cotinine were sig-
nificantly correlated (Spearman’s rank, r =
0.887; p < 0.001). Therefore, in the 30 cases
where the umbilical cord cotinine levels were
not available, the mothers’ values were used.
High/low cotinine was dichotomized using
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Table 1. Demographic and exposure characteristics of the population.a
All African American Dominican
(n = 214)a (n = 84) (n = 130)
Maternal age [year (mean ± SD)]b 24.3 ± 4.7b 23.8 ± 4.4 24.7 ± 4.9
Maternal education (%)
< High school 32 31 32.2
High school 45 44 46
> High school 23 25 22.8
Maternal ETS  39.3 47.6* 33.8
(percent who report a smoker in the home)
Maternal alcohol consumption 27.8 22 31.7
(percent who drank alcohol during pregnancy)
Maternal height [cm (mean ± SD)]b 162.6 ± 8.1 165.1 ± 8.4** 161 ± 7.6
Maternal prepregnancy weight [kg (mean ± SD)]b 67.4 ± 17.5 71.9 ± 19.8** 64.5 ± 15.2
Gestational age [weeks (mean ± SD)]b 39.5 ± 1.3 39.2 ± 1.4** 39.6 ± 1.2
Newborn birth weight [g (mean ± SD)] 3445.6 ± 475.3 3386.6 ± 502.4d 3483.8 ± 454.8
Newborn birth length [cm (mean ± SD)]b 51 ± 2.4 51.1 ± 2.8d 50.9 ± 2.2
Newborn head circumference [cm (mean ± SD)]b 34.2 ± 1.4 34 ± 1.6d 34.4 ± 1.2
Sex of newborn (% female) 53.7 51.2 55.4
Plasma cotinine (ng/mL)b,c
Percent of detectable 50 78.1** 31.9
Mean ± SD of detectable 0.41 ± 0.92 0.34 ± 0.30 0.52 ± 1.44
Percent high cotinine 33 54.8 19.5
Newborn BaP-DNA adducts (mean ± SD) 0.22 ± 0.14 0.23 ± 0.15 0.22 ± 0.13
(adducts/10–8 nucleotides)
aSubjects with BaP-DNA cord blood sample(s), complete questionnaire data, and birth outcome data. There were no signiﬁ-
cant differences between the overall parent population and the present subset in terms of demographic, questionnaire-
derived, and birth outcome variables shown in Table 1. Six babies were missing reliable data on birth length, and seven were
missing reliable data on head circumference. bArithmetic means are presented for ease of comparison with other studies;
however, the reported analyses are based on log-transformed data. cSubjects with cotinine > 15 ng/mL were excluded from
analysis; cotinine represents the level in cord blood or, if unavailable, the level in maternal blood. dBy multivariate Hotelling’s
t-test, at least one of these outcomes (weight, length, head circumference) was signiﬁcantly lower in African Americans
than in Dominicans (p < 0.01). *p ≤ 0.05 for African American versus Dominican (chi-square test for maternal ETS). **p ≤ 0.01
for African American versus Dominican (Student’s t-test for maternal height, prepregnancy weight, and gestational age).the median of all samples as the cutpoint
(0.0435 ng/mL).
The relationships between the exposure
variables and the birth outcomes were ana-
lyzed by multiple regression, adjusting for
known or potential confounders. In addition
to cord blood adducts dichotomized as
high/low and self-reported ETS (yes/no smok-
ers in the home), the final regression model
included covariates representing known or sus-
pected risk factors that were associated with
birth outcomes (p ≤ 0.1 by linear regression.
Birth outcomes were log transformed to pro-
vide a better ﬁt to the data and/or to approxi-
mate the normal distribution and stabilize the
variance. Models 1, 2, and 3 evaluated the
main effects of self-reported ETS, high/low
cotinine, and high/low BaP-DNA, adjusting
for potential confounders, including ethnicity,
body mass index, gestational age, dietary
PAHs, infant sex, and cesarean delivery (a
predictor of head circumference). Income
(< $10,000 or ≥ $10,000), parity (0 or ≥ 1 live
birth), social adversity (a composite score
based on marital status, income, education,
and whether currently on assistance), and
alcohol consumption (yes/no) were not signiﬁ-
cant predictors of outcomes (p > 0.1) and were
not included. The other variables, including
dietary PAHs, were included as covariates.
The final models tested the interaction
between adducts and ETS (or cotinine) using
appropriate interaction terms, adducts, and
ETS (or cotinine).
Results
Demographic and exposure characteristics
for the subjects included in the present analysis
are provided in Table 1 together with sum-
mary data on cord blood BaP-DNA and coti-
nine. The subset did not differ from the overall
cohort in terms of demographic variables.
Among subjects in the present analysis, 46%
of mothers and 49% of newborns had cotinine
levels > 0.05 and ≤ 15 ng/mL, indicative of
ETS exposure. Self-reported ETS and plasma
cotinine differed by ethnicity, with African
Americans being significantly more likely to
report ETS exposure (p ≤ 0.05) and to have a
higher rate of detectable cotinine (78.1 vs.
31.9%; p ≤ 0.01). Sixty-two percent of cord
and 61% of maternal blood samples had
nondetectable levels of BaP-DNA (< 0.25
adducts/10–8 nucleotides).
The mean birth weight was 3445.6 g
(SD = 475.3). Mean head circumference was
34.2 cm (SD = 1.4). Mean birth weight and
head circumference were lower, and there was
greater variability in these outcomes, among
African-American than among Dominican
infants. The differences between individual
outcomes were not signiﬁcant by t-test; how-
ever, by multivariate Hotelling’s t-test, at least
one of these outcomes (weight, length, head
circumference) was significantly lower in
African Americans (p < 0.01). Reﬂecting the
fact that all women had reached their third
trimester of pregnancy, only 3% percent of
infants were preterm (< 37 weeks of gesta-
tion). African-American infants had a signiﬁ-
cantly lower mean gestational age than did
Dominican infants (39.2 vs. 39.6 weeks,
p ≤ 0.01).
As shown in Table 2 by linear regression,
ETS exposure was associated with smaller
head circumference (β = –0.01, p = 0.04) after
adjusting for potential confounders (model 1).
Cotinine was signiﬁcantly associated with birth
length (β = –0.01, p = 0.05). By Spearman’s
test, BaP-DNA adducts were not signiﬁcantly
correlated with ETS, cotinine, or dietary
PAHs. BaP-DNA alone (either as a continuous
or dichotomous variable) was not signiﬁcantly
associated with birth outcomes. However, the
interaction between high/low adducts and ETS
was significant using either adduct variable.
For example, as shown in Table 3, the inter-
action effect of BaP-DNA and ETS was sig-
niﬁcant on birth weight (p = 0.05) and head
circumference (p = 0.01). Figure 1 shows the
effect of this interaction on birth weight and
head circumference. There was a 233-g (6.8%)
reduction of birth weight and 1-cm (2.9%)
reduction of head circumference in the ETS-
positive group with high BaP-DNA levels,
compared with the ETS-negative group with
low BaP-DNA levels. The interaction effect of
BaP-DNA and cotinine was not signiﬁcant.
Discussion
In this study we found an association between
ETS, with or without BaP-DNA adducts,
and two birth outcomes, namely decreased
birth weight and smaller head circumference,
after adjusting for potential confounders. This
association is of potential concern because,
although the literature is inconsistent, several
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Table 2. Associations between BaP-DNA exposure,
ETS, cotinine, and birth outcomes by multiple linear
regression.
Birth Birth Head
weight length circumference
Model 1a: ETS
β –0.02 –0.01 –0.01
p-Value 0.28 0.13 0.04
No. 214 208 207
Model 2a: Cotinineb
β –0.02 –0.01 –0.001
p-Value 0.42 0.05 0.85
No. 190 187 188
Model 3a: BaP-DNAc
β –0.01 –0.01 –0.006
p-Value 0.52 0.20 0.39
No. 214 208 207
aOther covariates are ethnicity, sex of newborns, maternal
body mass index, dietary PAH, and gestational age. For
head circumference, the model also included cesarean
delivery. bCotinine dichotomized as high/low using the
median. cDichotomized BaP-DNA using the median value
of adducts in the detectable range. Birth outcomes were
log transformed.
Table 3. Associations between all covariates and
birth outcomes by multiple linear regression.a,b
Birth Birth Head
weight length circumference
BaP-DNA
β 0.020 –0.005 0.007
p-Value 0.49 0.64 0.39
ETS
β –0.003 –0.007 –0.005
p-Value 0.90 0.32 0.43
Interaction
β –0.088 –0.014 –0.032
p-Value 0.05 0.39 0.01
Ethnicity
β –0.004 0.015 –0.012
p-Value 0.85 0.03 0.04
Sex
β 0.011 0.011 0.017
p-Value 0.55 0.07 0.002
Body mass index
β 0.005 0.001 0.001
p-Value < 0.001 0.01 0.01
Dietary PAHs
β –0.006 –0.002 0.001
p-Value 0.04 0.05 0.26
Gestational age
β 1.416 0.526 0.387
p-Value < 0.001 < 0.001 < 0.001
Cesarean
β 0.003
p-Value 0.63
No. 214 208 207
aCovariates included ethnicity (African American or
Dominican), sex of newborns, maternal body mass index
[weight (kg)/height (m)2], dietary PAHs (frequency of eat-
ing fried, broiled, or barbecued food during the preceding
2 weeks), and gestational age. For head circumference,
the model also included cesarean section (yes/no). bBirth
outcomes were log transformed.
Figure 1. Bar graph showing interaction effect of BaP-DNA and ETS on (A) birth weight and (B) head cir-
cumference. Abbreviations: ETS–, ETS-negative; ETS+, ETS-positive. The covariates in the graph are BaP-
DNA adducts (high/low) and self-reported ETS (yes/no). The graph shows a signiﬁcant interaction on birth
weight (p = 0.05) and on head circumference (p = 0.01). Other covariates in the models are shown in Table 3. 
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Low adducts
High adductsstudies have reported that reduction in birth
weight and head circumference at birth corre-
lates with lower IQ as well as poorer cognitive
functioning and school performance in child-
hood (Chaikind and Corman 1991; Desch
et al. 1990; Matte et al. 2001). In a prior
study, we found that the levels of PAH-DNA
adducts in cord blood of Caucasian newborns
in Poland, who were exposed to 10-fold higher
levels of PAHs in air pollution than was the
New York City cohort, were signiﬁcantly asso-
ciated with lower birth weight, reduced length,
and reduced head circumference (Perera et al.
1998). In the present study in New York City,
at lower levels of exposure, the effect of adducts
was seen only in the interaction with ETS.
The ﬁnding of a signiﬁcant interactive effect
between the two exposures, along with the
observed lack of correlation between adducts
and ETS, suggests that the effect of ETS is
largely caused by other non-PAH constituents
of tobacco smoke and that the adducts may
largely reﬂect other environmental sources of
PAHs as well as individual susceptibility to
them. We note that in this sample, ingestion of
dietary PAHs was not correlated with adducts.
Fetal toxicity from ETS and PAHs may be
caused by anti-estrogenic effects (Bui et al.
1986), binding of constituents to the human
aryl hydrocarbon receptor to induce P450
enzymes (Manchester et al. 1987), DNA dam-
age resulting in activation of apoptotic path-
ways (Meyn 1995; Nicol et al. 1995; Wood
and Youle 1995), binding to receptors for pla-
cental growth factors resulting in decreased
exchange of oxygen and nutrients, or direct
effects of carbon monoxide (Dejmek et al.
2000; National Research Council 1986).
In this study, there were no significant
differences in exposure–effect relationships
between African Americans and Dominicans.
The combination of high BaP-DNA adducts
and ETS exposure was associated with a 7%
reduction of birth weight and a 3% reduction
of head circumference.
PAHs are only one class of chemicals
among many found in particulate matter from
combustion sources. Nevertheless, our results
are consistent with ecologic studies showing
associations between ambient levels of air pol-
lutants (including total suspended particulate
matter) and low birth weight (Bobak 2000;
Chen and Omaye 2001; Ha et al. 2001). A
study in Northern Bohemia found that esti-
mated exposure to carcinogenic PAHs in early
gestation (based on ambient air monitoring
data) was associated with reduced fetal growth
(Dejmek et al. 2000).
This study has the advantage of being
based on individual prenatal exposure data
from biomarkers as well as extensive medical
records and questionnaire data. However, it is
limited by the modest sample of subjects (214)
for whom data from all relevant domains are
currently available. The study had insufﬁcient
power to examine size for gestational age, and
the study design precluded hypotheses related
to preterm delivery. Relationships observed in
low-income, minority women might be differ-
ent in women of other races or ethnic, cultural,
or socioeconomic backgrounds. However, we
reported previously that DNA damage from
PAHs was associated with worse birth out-
comes among Caucasians in Central Europe
who were exposed to air pollution from coal
burning (Perera et al. 1998). Finally, we were
able to measure biomarkers only at a single
time point. In cases of chronic exposure, a
single measure can be a representative internal
dosimeter; however, this may not be true if
exposures are sporadic and biomarkers have
short half-lives. This may explain why we saw a
stronger association between self-reported ETS
exposure and birth outcomes than between
cotinine and birth outcomes. Because cotinine
is a short-lived biomarker, cotinine measure-
ment at delivery may not be a good indicator
of levels throughout the pregnancy.
Conclusion
This study provides new molecular epidemio-
logic evidence that exposure to common envi-
ronmental pollutants (PAHs and ETS) at levels
currently encountered in New York City can
act in combination to adversely affect fetal
development.
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